Morgan Stanley Lantheus Holdings, Inc. Transaction History
Morgan Stanley
- $1.59 Trillion
- Q3 2025
A detailed history of Morgan Stanley transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Morgan Stanley holds 3,878,152 shares of LNTH stock, worth $206 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,878,152
Previous 740,809
423.5%
Holding current value
$206 Million
Previous $60.6 Million
228.01%
% of portfolio
0.01%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding LNTH
# of Institutions
485Shares Held
65.7MCall Options Held
563KPut Options Held
317K-
Black Rock Inc. New York, NY8.6MShares$456 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.95MShares$369 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X06.68MShares$354 Million0.17% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.48MShares$184 Million0.77% of portfolio
-
State Street Corp Boston, MA2.5MShares$132 Million0.0% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $3.64B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...